Smith, Julianne N. P.
Witkin, Matthew D.
Jogasuria, Alvin P.
Christo, Kelsey F.
Raffay, Thomas M.
Markowitz, Sanford D.
Desai, Amar B.
Funding for this research was provided by:
Foundation for the National Institutes of Health (K99HL135740, R35 CA197442)
Article History
Received: 12 December 2019
Accepted: 23 June 2020
First Online: 15 July 2020
Competing interests
: A.B.D. and S.D.M. hold patents relating to use of 15-PGDH inhibitors that have been licensed to Rodeo Therapeutics. S.D.M. is a founder of Rodeo Therapeutics, and S.D.M. and A.B.D. are consultants to Rodeo Therapeutics. Conflicts of interest are managed according to institutional guidelines and oversight by Case Western Reserve University. No conflict of interest pertains to any of the remaining authors.